GLP-1 Medications 2026: Complete Guide to All 11 FDA-Approved Options
Disclaimer: betterresultsbook.com contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated. This information, including any referenced scientific or clinical research, is made available for educational purposes only. Likewise, any published information relative to the dosing and administration of reference materials is made available strictly for reference and shall not be construed to encourage the self-administration or any human use of said reference materials. betterresultsbook.com makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available. However, research is not considered conclusive. betterresultsbook.com makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.
GLP-1 medications have transformed how we treat Type 2 diabetes and obesity. As someone who has spent months researching these drugs and speaking with healthcare providers, I can tell you the landscape of GLP-1 options is more complex than most people realize.
GLP-1 medications are prescription drugs that mimic the natural GLP-1 hormone to help manage blood sugar and support weight loss by reducing appetite, slowing digestion, and increasing insulin release when needed.
In 2026, there are 11 FDA-approved GLP-1 medications available, including popular options like Ozempic, Wegovy, Mounjaro, and Zepbound. This comprehensive guide covers every FDA-approved GLP-1 medication, how they work, their side effects, and how to access them through telehealth providers.
What Are GLP-1 Medications?
GLP-1 medications, also called GLP-1 receptor agonists or incretin mimetics, are a class of injectable and oral prescription drugs that mimic the glucagon-like peptide-1 hormone your body naturally produces.
Your body releases GLP-1 from your intestines after eating. This hormone signals your pancreas to release insulin, tells your liver to reduce glucose production, and sends fullness signals to your brain.
GLP-1 (Glucagon-like peptide-1): A naturally occurring hormone released by your gut after meals that helps regulate blood sugar and appetite. GLP-1 medications mimic this hormone’s effects but last much longer in the body.
The synthetic versions in medications are designed to resist breakdown in your body, so they work for hours or days instead of the minutes natural GLP-1 lasts.
Some newer medications like tirzepatide (Mounjaro and Zepbound) are dual agonists. They target both GLP-1 and GIP receptors, which may provide enhanced benefits for blood sugar control and weight loss based on clinical trial data.
How Do GLP-1 Medications Work?
GLP-1 medications work through four primary mechanisms in your body. Understanding these helps explain why they may be effective for both diabetes management and weight loss.
- Stimulate Insulin Release: When blood sugar rises after eating, GLP-1 medications signal your pancreas to release more insulin. This glucose-dependent action means they typically only increase insulin when needed, reducing hypoglycemia risk compared to some other diabetes medications.
- Suppress Glucagon: Your liver produces glucose through a hormone called glucagon. GLP-1 medications help suppress glucagon release when blood sugar is already elevated, preventing your liver from adding more glucose to your bloodstream.
- Slow Gastric Emptying: These medications slow how quickly food moves from your stomach to your intestines. This helps prevent blood sugar spikes after meals and may contribute to feeling full longer.
- Reduce Appetite: GLP-1 medications act on appetite centers in your brain, potentially reducing hunger and what many users describe as “food noise” – the constant thoughts about eating.
Based on our research: The appetite reduction effect is what users most commonly report as transformative. Many describe it as finally having a “normal” relationship with food where they can eat when hungry and stop when full.
The dual agonists like tirzepatide add GIP receptor activation, which research suggests may enhance insulin secretion and provide additional metabolic benefits beyond GLP-1 alone.
Complete List of FDA-Approved GLP-1 Medications
Here is a comprehensive comparison of all 11 FDA-approved GLP-1 medications available in 2026. This table provides a quick reference for the key differences between each option.
| Brand Name | Generic Name | FDA-Approved Uses | Administration | Frequency | User Rating |
|---|---|---|---|---|---|
| Ozempic | Semaglutide | Type 2 Diabetes | Injection | Weekly | 6.9/10 |
| Wegovy | Semaglutide | Weight Management | Injection | Weekly | 6.9/10 |
| Rybelsus | Semaglutide | Type 2 Diabetes | Oral Tablet | Daily | 6.9/10 |
| Mounjaro | Tirzepatide | Type 2 Diabetes | Injection | Weekly | 8.5/10 |
| Zepbound | Tirzepatide | Weight Management | Injection | Weekly | 8.5/10 |
| Victoza | Liraglutide | Type 2 Diabetes, CV Risk | Injection | Daily | 7.6/10 |
| Saxenda | Liraglutide | Weight Management | Injection | Daily | 7.6/10 |
| Trulicity | Dulaglutide | Type 2 Diabetes, CV Risk | Injection | Weekly | 5.3/10 |
| Byetta | Exenatide | Type 2 Diabetes | Injection | Twice Daily | 6.4/10 |
| Bydureon | Exenatide ER | Type 2 Diabetes | Injection | Weekly | 6.4/10 |
| Adlyxin | Lixisenatide | Type 2 Diabetes | Injection | Daily | N/A |
Semaglutide Medications: Ozempic, Wegovy, and Rybelsus
Semaglutide is currently the most popular GLP-1 drug class, manufactured by Novo Nordisk and available under three brand names for different uses.
Ozempic is FDA-approved for Type 2 diabetes management. It comes in doses of 0.25mg, 0.5mg, 1mg, and 2mg as a weekly injection. Clinical trials suggest average weight loss of 10-15% of body weight, though it is not officially approved for weight loss. Many physicians prescribe it off-label for this purpose.
Wegovy is the weight management version of semaglutide, FDA-approved for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related health condition. It reaches a higher maximum dose of 2.4mg weekly, and clinical trials suggest approximately 15% body weight loss on average.
In late 2026, the FDA also approved an oral form of Wegovy, starting at approximately $149/month, providing a needle-free option for weight management.
Rybelsus is the only oral semaglutide option, FDA-approved for Type 2 diabetes. Available in 3mg, 7mg, and 14mg tablets taken daily, it must be taken on an empty stomach with no more than 4 ounces of water, then wait 30 minutes before eating or drinking anything else.
Tirzepatide Medications: Mounjaro and Zepbound
Tirzepatide, manufactured by Eli Lilly, represents the newer class of dual GIP/GLP-1 receptor agonists. These medications target two incretin hormones instead of one.
Mounjaro is FDA-approved for Type 2 diabetes and comes in doses from 2.5mg to 15mg as a weekly injection. Clinical trials suggest weight loss of 15-20% of body weight, though it is not officially approved for weight management. It carries the highest user satisfaction rating at 8.5/10 based on nearly 2,600 reviews.
Zepbound is the weight management version of tirzepatide, FDA-approved for chronic weight management. Using the same dosing range as Mounjaro, clinical trials suggest approximately 20% body weight loss – the highest among currently available GLP-1 medications.
Zepbound is also available as vials for single-dose injections through Eli Lilly’s direct program.
Pro Tip: Tirzepatide medications tend to have higher user satisfaction ratings. Based on our research, users report they may be particularly effective but can have similar GI side effects during the titration period.
Liraglutide Medications: Victoza and Saxenda
Liraglutide was one of the earlier GLP-1 medications and remains widely used. Both versions require daily injections, which some users find less convenient than weekly options.
Victoza is FDA-approved for Type 2 diabetes and cardiovascular risk reduction. Doses range from 0.6mg to 1.8mg daily. It has a solid track record with long-term safety data available.
Saxenda is the weight management version, FDA-approved for chronic weight management. It uses higher doses up to 3mg daily. Clinical trials suggest average weight loss of 5-10% of body weight – less than semaglutide or tirzepatide but still clinically significant for many people.
Dulaglutide: Trulicity
Trulicity is a weekly GLP-1 injection FDA-approved for Type 2 diabetes and cardiovascular risk reduction. Available in doses from 0.75mg to 4.5mg, it uses an easy-to-use pen device.
User ratings are lower at 5.3/10 compared to other weekly options. Based on our research into user reviews, this may relate to side effect experiences, though individual responses vary significantly.
Exenatide Medications: Byetta and Bydureon
Exenatide was the first FDA-approved GLP-1 medication (2005), making it the original in this drug class.
Byetta requires twice-daily injections and is FDA-approved for Type 2 diabetes. Doses are 5mcg and 10mcg. The twice-daily dosing is less convenient than newer weekly options.
Bydureon is the extended-release version, requiring only weekly injections of 2mg. It carries the thyroid C-cell tumor boxed warning like other longer-acting GLP-1 medications.
Lixisenatide: Adlyxin
Adlyxin is a daily injectable GLP-1 FDA-approved for Type 2 diabetes. Doses are 10mcg and 20mcg. It is less commonly prescribed in the US than other GLP-1 options and has limited user review data available.
FDA-Approved Uses: Diabetes vs Weight Loss
Not all GLP-1 medications are approved for the same uses. This distinction matters for insurance coverage, prescribing, and off-label considerations.
| Approved For | Medications | Notes |
|---|---|---|
| Type 2 Diabetes Only | Ozempic, Rybelsus, Mounjaro, Victoza, Trulicity, Byetta, Bydureon, Adlyxin | May be used off-label for weight loss |
| Weight Management Only | Wegovy, Zepbound, Saxenda | Approved for BMI 30+ or BMI 27+ with conditions |
| Cardiovascular Risk Reduction | Victoza, Trulicity | Additional indication for heart disease risk |
Understanding Off-Label Use
Many physicians prescribe Ozempic and Mounjaro off-label for weight loss in patients who do not have Type 2 diabetes. Off-label prescribing is legal and common in medicine when the physician believes the medication may benefit the patient.
However, insurance coverage for off-label use is often denied. This is why Wegovy and Zepbound exist as separate products – they carry the FDA weight management indication that can support insurance claims.
GLP-1 Medications for Non-Diabetics
If you do not have diabetes but want a GLP-1 for weight loss, you have options. Wegovy, Zepbound, and Saxenda are all FDA-approved specifically for weight management in non-diabetic individuals who meet the criteria.
Eligibility typically requires a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, high cholesterol, or sleep apnea.
Side Effects and Safety Considerations
All GLP-1 medications share similar side effect profiles, though individual experiences vary. Understanding potential side effects helps set realistic expectations and know when to contact your healthcare provider.
Common Side Effects
Most users experience some gastrointestinal side effects, especially when starting treatment or increasing doses. These typically improve over 4-6 weeks as your body adjusts.
- Nausea: The most commonly reported side effect, affecting 20-40% of users. Often worst in the first weeks and typically improves with time.
- Vomiting: May occur alongside nausea, especially if eating too much or too quickly.
- Diarrhea: Common during dose increases. Staying hydrated is important.
- Constipation: Some users experience the opposite – slowed digestion can lead to constipation.
- Abdominal Pain: General stomach discomfort is common, particularly early in treatment.
- Decreased Appetite: This is technically a desired effect but can feel extreme for some users.
- Injection Site Reactions: Redness, swelling, or itching at injection sites may occur.
Serious Warnings and Risks
GLP-1 medications carry important warnings that you should discuss with your healthcare provider before starting treatment.
Boxed Warning – Thyroid C-Cell Tumors: In rodent studies, GLP-1 medications caused thyroid C-cell tumors. While it is unknown if this occurs in humans, GLP-1 medications are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Pancreatitis: Cases of acute pancreatitis have been reported. Symptoms include severe abdominal pain that may radiate to the back, with or without vomiting. Stop the medication and contact your doctor immediately if this occurs.
Gallbladder Problems: GLP-1 medications may increase risk of gallstones and gallbladder disease. Rapid weight loss itself also increases this risk.
Kidney Problems: Dehydration from nausea, vomiting, or diarrhea can worsen kidney function. Staying hydrated is essential, especially if you have existing kidney issues.
Diabetic Retinopathy: In patients with diabetes and existing retinopathy, rapid blood sugar improvement may temporarily worsen eye problems.
Managing Side Effects
Based on our research into user experiences, here are practical tips for managing common side effects:
- Eat smaller meals: Large portions overwhelm a slower-emptying stomach.
- Eat slowly: Give your body time to signal fullness.
- Avoid fatty or greasy foods: These are harder to digest and worsen nausea.
- Stay hydrated: Sip water throughout the day.
- Take your time with dose increases: Some users stay at lower doses longer to minimize side effects.
Who Should Not Take GLP-1 Medications
GLP-1 medications are contraindicated in certain situations:
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Pregnancy or planning to become pregnant
- History of severe allergic reaction to any GLP-1 medication
- Type 1 diabetes (these are not insulin replacements)
How to Get GLP-1 Medications?
GLP-1 medications require a prescription from a licensed healthcare provider. In 2026, you have several options for obtaining a prescription and accessing these medications.
Traditional Healthcare Routes
You can speak with your primary care physician or an endocrinologist about GLP-1 medications. They can evaluate your health history, current medications, and goals to determine if a GLP-1 is appropriate for you.
For weight loss specifically, some bariatric or weight management specialists focus on medication-assisted weight loss programs.
Telehealth GLP-1 Providers
Telehealth platforms have made accessing GLP-1 medications more convenient. These services typically include online consultations, prescription management, and medication delivery.
| # | Provider | Highlights | Price | |
|---|---|---|---|---|
| 01 | Ro Body Program |
|
$145/month | Visit Provider → |
| 02 | Hims Weight Loss |
|
Starting $199/month | Visit Provider → |
We may earn a commission at no extra cost to you.
Ro Body Program – Best for Insurance Navigation
Full-service digital health clinic offering GLP-1 medications with insurance concierge support.
Includes unlimited provider messaging, side effect management, and 1:1 health coaching.
Pros
- Insurance navigation support
- Brand-name medications available
- Unlimited provider messaging
- No long-term commitment
Cons
- Medication cost not included in membership
- Cannot coordinate government insurance plans
This post contains affiliate links. If you purchase through them, we may earn a commission (at no extra cost to you).
Ro Body Program focuses on helping patients access brand-name GLP-1 medications like Ozempic, Wegovy, and Zepbound. Their insurance concierge service helps navigate prior authorizations and coverage questions.
The $145/month membership includes consultations, ongoing care, and coaching. Medication costs are separate and depend on your insurance coverage.
Hims Weight Loss – Best for Affordable Cash-Pay Options
Offers both brand-name and compounded GLP-1 options with varying price points.
Compounded semaglutide available at lower costs for those without insurance coverage.
Pros
- Compounded GLP-1 starting at $199/month
- Oral medication kits available
- FSA/HSA eligible
- 24/7 online access
Cons
- Compounded medications not FDA-approved
- Brand-name meds expensive without insurance
- Not available in all states
This post contains affiliate links. If you purchase through them, we may earn a commission (at no extra cost to you).
Hims offers a range of GLP-1 options including compounded semaglutide starting at $199/month for those without insurance. They also carry brand-name medications for those with coverage.
Compounded medications are pharmacy-prepared versions that are not FDA-approved. They may offer cost savings but come with different regulatory oversight than brand-name products.
Disclaimer: Compounded medications are not FDA-approved and may not be available in all states. Discuss the differences between brand-name and compounded medications with your healthcare provider.
Insurance and Cost Considerations
GLP-1 medication costs vary dramatically based on insurance coverage:
- With good insurance: Copays may range from $25-$150/month
- Without insurance: Brand-name medications cost $900-$1,500+/month retail
- Compounded options: $200-$400/month through telehealth providers
Many insurers require prior authorization and may only cover GLP-1 medications for specific conditions. For weight loss, coverage remains inconsistent, though it is expanding.
How to Choose the Right GLP-1 Medication
With 11 options available, choosing the right GLP-1 medication depends on several factors. Here is a framework to guide your discussion with a healthcare provider.
Consider Your Primary Goal
If your primary goal is blood sugar management for Type 2 diabetes, any FDA-approved diabetes medication may be appropriate. If weight loss is your main objective, Wegovy, Zepbound, or Saxenda carry the weight management indication.
Injection vs Oral Preference
If needles are a concern, Rybelsus offers an oral semaglutide option for diabetes, and oral Wegovy became available in late 2026 for weight management. Keep in mind oral versions require specific timing and fasting requirements.
Dosing Frequency
Weekly injections (Ozempic, Wegovy, Mounjaro, Zepbound, Trulicity, Bydureon) are more convenient than daily options (Victoza, Saxenda, Rybelsus, Adlyxin) or twice-daily (Byetta).
Insurance Coverage
Your insurance formulary may favor certain medications. Check which GLP-1 medications are covered before making a decision.
Side Effect Tolerance
All GLP-1 medications have similar side effect profiles, but individual responses vary. If one medication causes intolerable side effects, switching to another may help.
Frequently Asked Questions
How exactly do GLP-1 drugs work?
GLP-1 drugs work by mimicking a natural hormone that regulates blood sugar and appetite. They stimulate insulin release when blood sugar is high, suppress glucagon to reduce liver glucose production, slow stomach emptying to prevent blood sugar spikes, and act on brain appetite centers to reduce hunger. These combined mechanisms help manage diabetes and support weight loss.
How much weight can I lose in 3 months on GLP-1?
Based on clinical trial data and user reports, weight loss in the first 3 months on GLP-1 medications typically ranges from 5-15 pounds, though individual results vary significantly. Most weight loss occurs during the titration period as doses increase. Tirzepatide (Mounjaro/Zepbound) users may see faster initial results compared to semaglutide users. Long-term studies suggest average total weight loss of 15-20% of body weight over 12-18 months.
What is the downside of GLP-1?
The main downsides of GLP-1 medications include gastrointestinal side effects like nausea, vomiting, and diarrhea, especially when starting or increasing doses. Other concerns include high cost without insurance coverage, the need for ongoing treatment to maintain results, potential for muscle loss alongside fat loss, and unknown long-term effects beyond 5-7 years. Some users also experience food aversion or difficulty eating enough.
How much will the new Wegovy pills cost?
The oral version of Wegovy, approved by the FDA in late 2024, starts at approximately $149 per month. This is significantly less expensive than the injectable version, which costs around $1,300 per month without insurance. Insurance coverage for oral Wegovy may vary, so check with your provider for specific pricing based on your plan.
What does GLP-1 make you feel like?
Most users report reduced appetite and fewer food cravings – often described as the quieting of constant thoughts about food. You may feel satisfied with smaller portions and less interested in snacking. Side effects during the first weeks can include nausea, fatigue, and stomach discomfort. Many users report increased energy once their body adjusts. Some describe feeling more in control of their eating for the first time.
How long to lose 20 pounds on GLP-1?
Based on clinical trial averages and user reports, losing 20 pounds on a GLP-1 medication typically takes 3-6 months. This varies based on starting weight, the specific medication, dosage titration schedule, diet and exercise habits, and individual metabolism. Tirzepatide users may reach this goal faster than semaglutide users based on clinical trial data showing greater average weight loss.
Does the GLP-1 pill actually work?
Yes, oral GLP-1 medications like Rybelsus work for blood sugar management in Type 2 diabetes. The newly approved oral Wegovy also works for weight loss. However, oral versions require strict dosing protocols – taking on an empty stomach with only a small amount of water and waiting 30 minutes before eating. Some studies suggest slightly less effectiveness than injectable versions, but they remain clinically effective options for those who prefer not to inject.
Why do so many people quit Ozempic?
People quit Ozempic and other GLP-1 medications for several reasons. Persistent gastrointestinal side effects that do not improve cause some to discontinue. High costs or loss of insurance coverage force others to stop. Some users achieve their goals and attempt to maintain results without medication. Supply shortages have also interrupted treatment. Research suggests many who quit experience weight regain, which is why ongoing treatment is often recommended.
Are GLP-1 medications safe long-term?
GLP-1 medications have been studied for 5-7 years in clinical trials and post-market surveillance. Current evidence suggests they are generally safe for long-term use when monitored by a healthcare provider. The main long-term concerns include the thyroid C-cell tumor risk (seen in rodents but not confirmed in humans), potential gallbladder issues, and effects of chronic appetite suppression. Regular check-ins with your doctor are recommended for ongoing monitoring.
Can non-diabetics take GLP-1 medications?
Yes, non-diabetics can take certain GLP-1 medications that are FDA-approved for weight management. Wegovy, Zepbound, and Saxenda are specifically approved for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition. Ozempic and Mounjaro may be prescribed off-label for weight loss in non-diabetics, though insurance may not cover this use.
The Bottom Line on GLP-1 Medications
GLP-1 medications represent a significant advancement in treating Type 2 diabetes and obesity. With 11 FDA-approved options ranging from daily oral tablets to weekly injections, there are more choices than ever for patients and healthcare providers.
The newest dual agonists like tirzepatide (Mounjaro and Zepbound) show the highest efficacy in clinical trials, with average weight loss approaching 20% of body weight. Semaglutide options (Ozempic, Wegovy, Rybelsus) remain popular and effective choices with strong safety profiles.
Side effects, particularly gastrointestinal symptoms, are common but typically improve over time. The biggest barriers remain cost and insurance coverage, though telehealth options and compounded medications are expanding access for many people.
If you are considering a GLP-1 medication, consult with a healthcare provider who can evaluate your health history, discuss the options, and help you choose the medication that best fits your goals and circumstances.
This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any weight-loss or diabetes medication. GLP-1 medications are prescription drugs with potential risks and side effects that should be discussed with your doctor.
